Single center experience of 90Y-Ibritumomab tiuxetan in the older population with non-hodgkin lymphoma.

被引：0

作者：

Agrawal, Vaibhav ^{[1
]}

Castillo, Jose Isaac ^{[1
]}

Raup, Kelly ^{[1
]}

Girton, Treanna ^{[1
]}

Collins, Scott R. ^{[1
]}

Brady, James O. ^{[1
]}

Khan, Sharif S. ^{[1
]}

Vadakara, Joseph ^{[1
]}

机构：

[1] Geisinger Med Ctr, Danville, PA 17822 USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期

关键词：

D O I：

10.1200/JCO.2016.34.15_suppl.e19035

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

e19035

引用

页数：2

共 50 条

[31] RIT with Y-90-Ibritumomab Tiuxetan in Follicular Non-Hodgkin Lymphoma: Evaluation of Recent Outcomes in a Single Institution [J].

Miguel, Marcio ;

Campos, Andrade ;

Limon, Anel E. Montes ;

Grasa, Jose Maria ;

Lievano, Paola ;

Baringo, Teresa ;

Giraldo, Pilar .

JOURNAL OF ONCOLOGY, 2012, 2012

[32] 90Y-ibritumomab treatment for relapsed and/or refractory B cell type non-hodgkin's lymphoma.: Multiinstitutional Argentinian study [J].

Cacchione, Roberto ;

Dupont, Juan ;

Milone, Jorge ;

Bordone, Javier ;

Garay, Guy ;

Ardaiz, Maria ;

Castro-Rios, Miguel ;

Prates, Virginia ;

Basso, Alfredo ;

Labstrebner, Marcelo ;

Avila, Graciela ;

Diaz, Alicia ;

Argentieri, Daniel ;

Rudoy, Silvia ;

Trouboul, Alicia ;

Palmer, Luis ;

Pombo, Gonzalo ;

Rappaciotti, Silvina ;

Negri, Pedro ;

Lafalse, Diana ;

Riera, Leandro ;

de Tezanos-Pinto, Miguel ;

Riveros, Dardo ;

Arnold, Mario Brown ;

Carrasco, Antonio ;

Bezares, Fernando .

BLOOD, 2007, 110 (11) :192B-192B

[33] 90Y-ibritumomab treatment for relapsed and/or refractory B cell type non-Hodgkin's lymphoma.: Multiinstitutional Argentinian study [J].

Cacchione, R. ;

Dupont, J. ;

Milone, J. ;

Bordone, J. ;

Riera, L. ;

Ardaiz, M. ;

Castro-Rios, M. ;

Iabstrebner, M. ;

Pombo, G. ;

Basso, A. ;

Avila, G. ;

Rodriguez, S. ;

Tartas, N. ;

Plana, J. ;

Garay, G. ;

Riveros, D. ;

Carrasco, A. ;

Bezares, F. .

HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 :111-111

[34] Efficacy and safety of 90Y ibritumomab tiuxetan (Zevalin) radioimmunotherapy for non-Hodgkin's lymphoma [J].

Witzig, TE .

SEMINARS IN ONCOLOGY, 2003, 30 (06) :11-16

[35] Safety and efficacy of yttrium-90 ibritumomab tiuxetan in older patients with non-hodgkin's lymphoma [J].

Emmanouilides, Christos ;

Witzig, Thomas E. ;

Wiseman, Gregory A. ;

Gordon, Leo I. ;

Wang, Hua ;

Schilder, Russell ;

Saville, M. Wayne ;

Flinn, Ian ;

Molina, Arturo .

CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2007, 22 (05) :684-691

[36] 90Y-ibritumomab tiuxetan (Zevalin®) consolidation in non-Hodgkin's B lymphoma: severe haematological toxicity reported in two Mantle patients [J].

Pena, F. J. ;

Crespo-Jara, A. ;

Sureda, M. ;

Redal, M. C. ;

Garcia-Cases, F. ;

Rebello, J. ;

Fernandez, P. L. ;

Evgenyeva, E. ;

Brugarolas, A. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2008, 35 :S149-S149

[37] RIT with 90Y Ibritumomab Tiuxetan in Patients with Non-Hodgkin Lymphoma Over 65 Years [J].

Andrade, Marcio M., Sr. ;

Montes, Anel ;

Murillo, Ilda ;

Grasa, Jose M., Sr. ;

Baringo, Teresa ;

Giraldo, Pilar .

BLOOD, 2012, 120 (21)

[38] Ibritumomab tiuxetan (Zevalin) for non-Hodgkin's lymphoma [J].

不详 .

MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2002, 44 (1144) :101-102

[39] Radioimmunotherapy for NHL:: Experience of 90Y-ibritumomab tiuxetan in clinical practice [J].

Hagenbeek, A .

LEUKEMIA & LYMPHOMA, 2003, 44 :S37-S47

[40] Radioimmunotherapy with 90Y-ibritumomab tiuxetan (Zevalin) in treatment of CD 20 positive mature B-cell non-Hodgkin's lymphoma: Initial experience. [J].

Khan, H. A. K. ;

Shemmari, S. A. S. ;

Sajnani, K. S. ;

Mohannadi, S. A. M. ;

Huda, F. A. H. ;

Usmani, S. U. ;

Abdulla, M. M. A. ;

Mahmoud, S. A. D. ;

Javaid, A. J. ;

Sahi, Z. M. S. ;

Wael, W. A. ;

Ghaniem, I. G. ;

Parekh, H. G. P. .

EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 :S168-S168

← 1 2 3 4 5 →